作为一个潜在的抗病毒药物,Piceatannol在多个阶段对抗疫苗病毒
Liyuan Zhang1,2, Yuwen Liu2, Daoqun Li2
1Department of Clinical Laboratory Medicine, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China.
Frontiers in microbiology
|February 23, 2026
概括
一种天然化合物Piceatannol通过抑制疫苗病毒 (VACV) 复制和传播,显示出对抗mpox病毒 (MPXV) 的承诺. 它有效地向病毒感染的多个阶段,表明对骨质疏松病毒感染的治疗潜力.
科学领域:
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
背景情况:
- 麻疹病毒 (MPXV) 爆发突显了迫切需要有效的抗病毒疗法.
- 疫苗病毒 (VACV) 由于遗传相似性,可以作为研究mopox病毒的相关模型.
研究的目的:
- 为了评估piceatannol对orthopoxvirus的抗病毒活性.
- 研究piceatannol对疫苗病毒 (VACV) 的作用机制.
主要方法:
- 在体外抗病毒测定对VACV.
- 细胞测试以评估病毒的进入和复制.
- 分子对接研究,以预测结合相互作用.
- 对不同病毒形式的杀毒试验.
主要成果:
- 皮塞坦诺醇显著抑制了VACV复制,EC50值为76.27微米 (EEV) 和63.93微米 (IMV).
- 皮塞坦诺尔减少了病毒进入和在HeLa细胞中的复制.
- 分子对接表明与VACV F13蛋白的稳定相互作用,表明抑制EEV生成.
- 皮塞坦诺显示出杀毒效应,并在细胞培养物中限制病毒的传播.
结论:
- 皮塞阿坦诺露显示出广泛的抗病毒活性,可以对抗骨病毒.
- 皮塞坦诺通过抑制病毒复制,进入和传播而起作用.
- 皮塞坦诺尔是治疗莫波克斯和相关感染的有前途的候选药物.
相关概念视频
Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Chickenpox
Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


